On January 25th Biostar Stem Cell Research Institute, headed by Dr. Jeong Chan Ra, and jointly operated by Nature Cell and R Bio, has announced the registration of the Patent “Production Method of Stem Cells for Intravascular Administration” (Application number: 10-2012-0040488, 2012), with the European Patent Office.
Read more
The Biostar Stem Cell Research Centre (CEO: Ra Jeong Chan) run by Nature Cell and R-Bio announced that it has completed a registration process for an orphan drug in developmental phase for Parry-Romberg Disease, by receiving an official recommendation by The Korean Society of Plastic and Reconstructive Surgeons.
Read more
A stem cell treatment for Alzheimer’s disease was developed by Korean bio-company Nature Cell (President Jeong-chan Ra) and approved by the US FDA for commercial clinical trials in the US.
Read moreNature Cell announced on October 4 that the results of phases 1 and 2 of Vascostem’s clinical trials—for a stem cell-based treatment for Buerger’s disease—had been presented by international academic journal Cell Medicine.
Read more
A successful case of adult stem cell treatment was recently announced. It involves a therapy that cultivates Buerger’s disease patients’ stem cells extracted from their fat and later injected back into their bodies.
Read more
Nature Cell announced on May 6 that its stem cell-based medicine to cure Buerger’s disease, Vascostem, had been approved for the US FDA’s Orphan Drug Designation Program. The approval was given a mere 100 days after the Biostar Stem Cell Research Institute had applied for it on January 18.
Read more
Biostar Stem Cell Research Institute
08506
305, Lotte IT Castle Building #2, 550-1, Gasan-dong, Geumcheon-gu, Seoul
R Bio Co.,Ltd.
+82 -2-858-8021~5
Most Commented